A device history record review was completed for provided material number 306575 and lot number 3199057.The review did not reveal any detected abnormalities during the production process that could have contributed to this reported incident.To aid in the investigation of this issue, one (1) picture sample was received for evaluation by our quality team.Through examination of the picture, a dark spot on the barrel label was observed on the syringe.Through the picture sample alone, it is not clear if the spot is within the solution or what the spot composition is.It is also unknown if the particle was already in the solution prior to diluting with antibiotics, if it appeared after the dilution, or if the syringe was used to aspirate.As the affected sample was not available for return, retained samples of the same lot number were obtained from the manufacturing facility.The retained samples did not reveal any particulates.At this time an exact cause related to the manufacturing process could not be determined for this incident.Bd posiflush sp syringes are intended to be used for flushing only of in-situ peripheral intravenous catheters (pivcs), peripherally inserted central catheters (piccs), central venous catheters (cvcs),and implanted venous access ports.Bd posiflush sp is not intended for dry product reconstitution, for medication dilution, or where intravenous therapy with sodium chloride is indicated.The syringe consists of a ready to use syringe, which is pre-filled with an injectable sterile non-pyrogenic and isotonic 0.9% sodium chloride solution.The syringe is not to be re-sterilized or re-used.There is a misuse of the syringe as it was used to dilute antibiotics and there is the possibility of contamination of the saline solution.The bd manufacturing process has several preventive measures in place to prevent contamination of the saline solution including inspections and routine washes of the filling area.At this time, further action has not been determined necessary.Our quality team will continue to closely monitor the manufacturing process for signs of this potential defect and any emerging trends.
|